StonvexLoading…
StonvexStonvexStonvexCore line items from LXRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $6.00M | $1.11M | $0.00 | $0.00 |
Operating Income | $-197.12M | $-171.75M | $-100.76M | $-87.09M |
Net Income | $-200.40M | $-177.12M | $-101.94M | $-87.76M |
EPS (Diluted) | $-0.63 | $-0.80 | $-0.62 | $-0.60 |
Total Assets | $298.42M | $229.43M | $194.30M | $136.91M |
Total Liabilities | $152.47M | $136.32M | $77.17M | $23.31M |
Cash & Equivalents | $66.66M | $22.46M | $46.34M | $64.06M |
Free Cash Flow OCF − CapEx | $-179.81M | $-162.37M | $-90.18M | $-88.24M |
Shares Outstanding | 363.02M | 221.13M | 165.73M | 145.65M |